New

Agilent Technologies

The AI engine Fit Assessment

Beta

Agilent develops digital solutions that enhance laboratory efficiency and operates within the pharmaceutical industry, particularly in biopharmaceuticals.

Blurb

Agilent Technologies addresses the scientific and laboratory management needs of analytical scientists and clinical researchers.

HQ Location

Santa Clara (United States)

Founded

1999

Employees

+10000

Total funding raised

$500.00M

Funding Status

Post-IPO Debt, $500.00M, September 5, 2019

Agilent customers are finding new ways to treat cancer, ensure food, water, air, and medicine quality and safety, discover new drug treatments, research infectious diseases, and create alternative energy solutions for a greener planet. From start to finish, we have them covered with our vast product solutions and services portfolio.



Around the world, Agilent’s people bring innovations, technologies, and services to the forefront of science. Our teams design and manufacture a wide array of advanced analytical, research, and diagnostic solutions and tools for use inside and outside laboratories.



Additionally, the unique expertise of Agilent’s CrossLab and technical teams provides valuable insight and support to our customers, helping them fully optimize their laboratories and resources to better focus on what's important: bringing great science to life.



In fiscal 2022, Agilent Technologies generated revenue of (US) $6.85 billion.